Rivastigmine Tartrate
NDC 65862-650, Rivastigmine Tartrate, capsule, from Aurobindo Pharma Limited.
- Product NDC
- 65862-650
- Status
- Listed
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA204572
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/65862-650 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RIVASTIGMINE TARTRATE4.5 mg/1
Pharmacologic classes
Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 65862-650-05 | 65862065005 | 500 CAPSULE in 1 BOTTLE (65862-650-05) |
| 65862-650-60 | 65862065060 | 60 CAPSULE in 1 BOTTLE (65862-650-60) |
| 65862-650-78 | 65862065078 | 10 BLISTER PACK in 1 CARTON (65862-650-78) / 10 CAPSULE in 1 BLISTER PACK (65862-650-10) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c246a0e5-1e77-41ee-a7b3-384f21f2f2e0NADAC price for package 65862065060
GET /v1/drugs/nadac/65862065060
Use it
Look up 65862-650 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/65862-650 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 65862-650. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.